Korsana Biosciences completes a private placement closing, raising $380 million led by Fairmount and Venrock Healthcare Capital Partners to fund operations into 2029.
Amount Raised
$380 Million
Round Type
Post-IPO Equity
WalthamBiotechnologyHealthcareHealth CareTherapeuticsInvestors
Description
Korsana Biosciences announced the completion of a $380 million private financing from new and existing investors before its merger with Cyclerion Therapeutics. This funding is expected to support multiple clinical milestones for KRSA-028 and ensure financial stability into 2029. Shares will begin trading on Nasdaq under the ticker symbol “KRSA” on September 9, 2026.
Quick answer
Korsana Biosciences raised $380 Million in a Post-IPO Equity round, dated September 8, 2026. Investors: Janus Henderson Investors, Vivo Capital, General Atlantic, Tcgx, Forbion, Wellington Management, Commodore Capital and RA Capital Management. Korsana Biosciences is based in Waltham, Massachusetts, United States.
- How much did Korsana Biosciences raise?
- Korsana Biosciences raised $380 Million in a Post-IPO Equity round on September 8, 2026.
- Who invested in Korsana Biosciences?
- Janus Henderson Investors, Vivo Capital, General Atlantic, Tcgx, Forbion, Wellington Management, Commodore Capital and RA Capital Management are named as investors in this round.
- What does Korsana Biosciences do?
- Korsana Biosciences, Inc. is a biotechnology company focused on discovering and developing novel therapies for neurodegenerative diseases, particularly Alzheimer's disease.
- Where is Korsana Biosciences based and how big is it?
- Korsana Biosciences is based in Waltham, Massachusetts, United States. Fundz records about 37 employees.
- Who are the decision-makers at Korsana Biosciences?
- Fundz holds 3 contacts at Korsana Biosciences, including the Head of Financial Planning & Analysis. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Therapeutics around the same time
Companies in the same sectors as Korsana Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Recursion Pharmaceuticals raised $200M (Post-IPO Equity) on October 15, 2026.
- Os Therapies raised $7.2M on October 15, 2026.
- Tempest Therapeutics raised $7.5M on September 15, 2026.
- CytoDyn raised $17M on September 1, 2026.
- BioLineRx Ltd raised $3.8M on August 27, 2026.
- Amylyx Pharmaceuticals raised $500M (Post-IPO Equity) on August 20, 2026.
Who to call at Korsana Biosciences, and when
A new round usually means Korsana Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Korsana Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Korsana Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Korsana Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Korsana Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Korsana Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.